<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="discussion" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Epidemiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Epidemiol</journal-id>
<journal-id journal-id-type="publisher-id">aje</journal-id>
<journal-title-group>
<journal-title>American Journal of Epidemiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-9262</issn>
<issn pub-type="epub">1476-6256</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30877295</article-id>
<article-id pub-id-type="pmc">7109842</article-id>
<article-id pub-id-type="doi">10.1093/aje/kwy264</article-id>
<article-id pub-id-type="publisher-id">kwy264</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Commentaries</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Emerging Challenges and Opportunities in Infectious Disease Epidemiology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lewnard</surname>
<given-names>Joseph A</given-names>
</name>
<xref ref-type="corresp" rid="kwy264cor1"></xref>
<xref ref-type="aff" rid="AF0001"></xref>
<!--<email>jlewnard@berkeley.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reingold</surname>
<given-names>Arthur L</given-names>
</name>
<xref ref-type="aff" rid="AF0001"></xref>
</contrib>
</contrib-group>
<aff id="AF0001">Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, California </aff>
<author-notes>
<corresp id="kwy264cor1">Correspondence to Dr. Joseph A. Lewnard, Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Berkeley, CA 94720 (e-mail: <email>jlewnard@berkeley.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-03-16" pub-type="epub">
<day>16</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>188</volume>
<issue>5</issue>
<fpage>873</fpage>
<lpage>882</lpage>
<history>
<date date-type="received">
<day>07</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p>
</license>
</permissions>
<self-uri xlink:href="kwy264.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Much of the intellectual tradition of modern epidemiology stems from efforts to understand and combat chronic diseases persisting through the 20th century epidemiologic transition of countries such as the United States and United Kingdom. After decades of relative obscurity, infectious disease epidemiology has undergone an intellectual rebirth in recent years amid increasing recognition of the threat posed by both new and familiar pathogens. Here, we review the emerging coalescence of infectious disease epidemiology around a core set of study designs and statistical methods bearing little resemblance to the chronic disease epidemiology toolkit. We offer our outlook on challenges and opportunities facing the field, including the integration of novel molecular and digital information sources into disease surveillance, the assimilation of such data into models of pathogen spread, and the increasing contribution of models to public health practice. We next consider emerging paradigms in causal inference for infectious diseases, ranging from approaches to evaluating vaccines and antimicrobial therapies to the task of ascribing clinical syndromes to etiologic microorganisms, an age-old problem transformed by our increasing ability to characterize human-associated microbiota. These areas represent an increasingly important component of epidemiology training programs for future generations of researchers and practitioners.</p>
</abstract>
<kwd-group>
<kwd>infectious diseases</kwd>
<kwd>methods</kwd>
<kwd>modeling</kwd>
<kwd>surveillance</kwd>
</kwd-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
<body>
<p>The priority afforded to infectious diseases within epidemiologic research has been fluid over the past 200 years or longer. Despite the lasting prominence of early investigations into measles, cholera, plague, typhoid fever, malaria, and yellow fever (<xref ref-type="bibr" rid="kwy264C1">1</xref>–<xref ref-type="bibr" rid="kwy264C6">6</xref>), the intellectual tradition of modern epidemiology stems largely from studies of chronic diseases dating to the post-World War II era, when such conditions came to surpass infectious diseases in morbidity and mortality in high-income countries amid improvements in living conditions and the introduction of numerous antibiotics and vaccines. This epidemiologic transition co-occurred with a shift in focus for epidemiologic research (and training programs) toward the multifactorial etiology of chronic conditions (<xref ref-type="bibr" rid="kwy264C7">7</xref>). In parallel, early 20th-century work on the “dependent happenings” of communicable diseases (<xref ref-type="bibr" rid="kwy264C8">8</xref>–<xref ref-type="bibr" rid="kwy264C11">11</xref>) yielded to the development of today’s core biostatistical methods for chronic diseases, premised on the independence of outcomes among subjects (<xref ref-type="bibr" rid="kwy264C12">12</xref>–<xref ref-type="bibr" rid="kwy264C14">14</xref>).</p>
<p>Since the late 20th century, the emergence of human immunodeficiency virus and acquired immunodeficiency syndrome and other infections has renewed interest in infectious diseases and their health, economic, and security implications (<xref ref-type="bibr" rid="kwy264C15">15</xref>). Outbreaks of severe acute respiratory syndrome, pandemic influenza A H1N1, Ebola virus (EBOV), and Zika virus have prompted international responses, whereas influenza A H7N9 and H5N1, Lassa fever virus, Nipah virus, and Middle East respiratory syndrome coronavirus, among other agents, have been a source of regional concern. The incidence and endemic range of “neglected” infections, including dengue and cholera (<xref ref-type="bibr" rid="kwy264C16">16</xref>, <xref ref-type="bibr" rid="kwy264C17">17</xref>), have expanded, and antimicrobial resistance has threatened to derail the control of tuberculosis, typhoid, malaria, gonorrhea, yaws, and invasive bacterial infections (<xref ref-type="bibr" rid="kwy264C18">18</xref>–<xref ref-type="bibr" rid="kwy264C23">23</xref>). Although highly effective vaccines are available, measles and yellow fever have resurged on multiple continents, due to gaps in vaccine coverage (<xref ref-type="bibr" rid="kwy264C24">24</xref>, <xref ref-type="bibr" rid="kwy264C25">25</xref>), while short-lived vaccine-induced protection has facilitated unexpected resurgences in diseases once on the path to elimination, such as pertussis and mumps (<xref ref-type="bibr" rid="kwy264C26">26</xref>, <xref ref-type="bibr" rid="kwy264C27">27</xref>).</p>
<p>After decades of relative obscurity in the mid-20th century, infectious disease epidemiology has experienced an intellectual rebirth in response to disease emergence. Repopulation of this field by scientists trained not only in clinical medicine but ecology, demography, and quantitative sciences has led to the adoption of methods scarcely addressed in traditional public health training programs. Cluster-randomized trial designs, for example, have become commonplace for evaluating infectious disease interventions, quantifying indirect effects resulting from contagion (<xref ref-type="bibr" rid="kwy264C28">28</xref>). Classical models of ecological dynamics have been adapted to address the transmission and control of infectious agents, while our expanding ability to integrate such models with epidemiologic data through Bayesian statistics has enhanced their relevance to policymaking (<xref ref-type="bibr" rid="kwy264C29">29</xref>–<xref ref-type="bibr" rid="kwy264C31">31</xref>). Most recently, sequencing and phylogenetic analysis have afforded an unprecedented view into the population structure and dynamics of pathogens (<xref ref-type="bibr" rid="kwy264C32">32</xref>, <xref ref-type="bibr" rid="kwy264C33">33</xref>).</p>
<p>Here, we review developments in infectious disease epidemiology together with their implications for research and practice, and for the training of future epidemiologists. We first consider the role of epidemiologic surveillance in the context of pathogen emergence and the integration of surveillance data into quantitative studies of transmission. Next, we discuss challenges in causal inference, including the evaluation of public health interventions against emerging pathogens and the difficulties of attributing clinical syndromes to microbial agents.</p>
<sec id="kwy264s2">
<title>SURVEILLANCE OF EMERGING INFECTIONS</title>
<sec id="kwy264s2a">
<title>Public health practice</title>
<p>Surveillance justifiably has been seen as a core public health function, with its important role articulated by Langmuir in 1963 (<xref ref-type="bibr" rid="kwy264C34">34</xref>). In the United States and elsewhere, surveillance for diverse infectious (and noninfectious) diseases has typically relied on an essentially passive system of reporting by health-care providers or laboratories, often mandated by public health laws. Although such passive systems of disease reporting have proven invaluable, their limitations, such as incomplete, often inconsistent detection of cases and delayed detection of outbreaks, are well documented (<xref ref-type="bibr" rid="kwy264C35">35</xref>). As a result, active surveillance systems that do not depend on providers and laboratories to report have been developed and promoted.</p>
<p>The Centers for Disease Control and Prevention–funded Emerging Infections Program and its components (e.g., Foodnet, ABCs), initiated in 1994, is 1 notable example of such a system, as are international versions promoted through the Centers for Disease Control and Prevention’s Global Health Security initiative (<xref ref-type="bibr" rid="kwy264C36">36</xref>). Such systems, while expensive to develop and maintain, are of great value, especially when they collect biological specimens (e.g., isolates of bacterial and viral pathogens) for typing and support analytic epidemiologic studies (e.g., case-control studies of vaccine effectiveness (<xref ref-type="bibr" rid="kwy264C37">37</xref>)). Nevertheless, these systems, too, may have limitations, particularly in their ability to detect in a timely fashion outbreaks caused by novel microbial agents, prompting interest in alternative methods. In this article, we consider proposed alternatives, highlighting their benefits and challenges.</p>
</sec>
<sec id="kwy264s2b">
<title>Surveillance for disease emergence</title>
<p>Beyond efforts to quantify the incidence of infectious diseases of known etiology, disease surveillance has been advocated as a means of mitigating the threat posed by novel pathogens. Large-scale efforts to identify pathogens with the potential to spill over from animals to humans have received notable investment, for instance from the US Agency for International Development Emerging Pandemic Threats program (<xref ref-type="bibr" rid="kwy264C38">38</xref>). More recently, metagenomic sequencing has enabled the number of known viruses to be multiplied in such studies (<xref ref-type="bibr" rid="kwy264C39">39</xref>). The aim of those working on the Global Virome Project, launched in 2018, to characterize within 10 years all 1.6 million viruses thought to exist (<xref ref-type="bibr" rid="kwy264C40">40</xref>).</p>
<p>However, the pathway for translating data sets produced by such activities into actionable threat-reduction programs remains unclear. That only approximately 250 viruses are known to infect humans (and an even smaller handful to cause major epidemics) may constrain the value of large-scale virus discovery for identifying high-risk pathogens, as well as viral determinants of pathogenic potential (<xref ref-type="bibr" rid="kwy264C41">41</xref>). Spillover events causing recent epidemics—including H1N1 in Mexico, Middle East respiratory syndrome in Saudi Arabia, and EBOV in West Africa—have been poorly predicted by factors long believed to drive disease emergence (<xref ref-type="bibr" rid="kwy264C42">42</xref>). Accordingly, interest in expanding our catalogue of potential pathogens should be weighed against our persisting need to enhance the detection and control of outbreaks of known pathogens (<xref ref-type="bibr" rid="kwy264C43">43</xref>). For instance, 2 EBOV epidemics in the Democratic Republic of the Congo in 2018 took weeks to be identified, with dozens of suspected cases having already accumulated (<xref ref-type="bibr" rid="kwy264C44">44</xref>, <xref ref-type="bibr" rid="kwy264C45">45</xref>).</p>
<p>Serological studies have received increasing enthusiasm for monitoring emerging pathogens of significance to humans (<xref ref-type="bibr" rid="kwy264C41">41</xref>, <xref ref-type="bibr" rid="kwy264C46">46</xref>). The prevalence of antibodies indicating previous exposure may provide valuable information about the frequency of animal-human spillover events and the potential for person-to-person spread, overcoming reporting biases that favor detection of large outbreaks under traditional surveillance. Moreover, the low cost of multiplex assays makes integrated surveillance of multiple pathogens plausible. Although serosurveys have bolstered recent efforts to understand the geographic range and clinical spectrum of EBOV and Zika virus infections (<xref ref-type="bibr" rid="kwy264C47">47</xref>, <xref ref-type="bibr" rid="kwy264C48">48</xref>), the enhancement of dengue hemorrhagic fever risk by prior exposure (<xref ref-type="bibr" rid="kwy264C49">49</xref>), and the role of immunologic history in influenza susceptibility and vaccine response (<xref ref-type="bibr" rid="kwy264C50">50</xref>), there remain few examples of public health programs undertaking serological studies for routine surveillance, at least in civilian populations (<xref ref-type="bibr" rid="kwy264C51">51</xref>).</p>
</sec>
<sec id="kwy264s2c">
<title>Emerging data and analytics</title>
<p>Outside of laboratory-based surveillance, the increasing availability of passively collected “Big Data” on the health and behaviors of individuals has prompted enthusiasm about enhancing disease surveillance through alternative data streams. Initiatives such as the ProMED-mail network and HealthMap (<xref ref-type="bibr" rid="kwy264C52">52</xref>, <xref ref-type="bibr" rid="kwy264C53">53</xref>) compile and disseminate news about outbreaks from media and other sources, aiming to trigger investigation by public health organizations. Data such as emergency department visits, medication sales, online search queries, and social media postings have also been suggested as real-time indicators of outbreak activity, although their integration into public health responses remains a subject of debate (<xref ref-type="bibr" rid="kwy264C54">54</xref>–<xref ref-type="bibr" rid="kwy264C56">56</xref>). The need to overcome reporting biases is a central challenge, because observations may be too nonspecific to distinguish between meaningful and spurious signals in settings with high technological capacity while also being insensitive to even high-risk events in resource-poor settings (<xref ref-type="bibr" rid="kwy264C57">57</xref>, <xref ref-type="bibr" rid="kwy264C58">58</xref>). Although nontraditional data sources have, in some applications, supported inferences about epidemic dynamics (<xref ref-type="bibr" rid="kwy264C59">59</xref>), limited information about cases from such sources remains a barrier. For instance, models fitted from news reports of recent measles and mumps outbreaks have yielded considerable underestimates of vaccine coverage (<xref ref-type="bibr" rid="kwy264C60">60</xref>–<xref ref-type="bibr" rid="kwy264C62">62</xref>), underscoring the importance of field investigations.</p>
<p>Forecasting the incidence of diseases has been a more successful application of these emerging data streams and data-analytic approaches. Although the acknowledged failure of Google Flu Trends—a prediction approach based on Internet search behavior—yielded important lessons about nonmechanistic forecasts, approaches based on machine learning and crowd-sourced human judgment have provided the most accurate within-season predictions of US influenza activity in recent comparisons (<xref ref-type="bibr" rid="kwy264C63">63</xref>–<xref ref-type="bibr" rid="kwy264C65">65</xref>). Given expanding interest in forecasting among researchers, funding agencies, and other stakeholders, there is a clear and compelling need to evaluate whether such forecasts can enhance the success and efficiency of public health response efforts.</p>
</sec>
</sec>
<sec id="kwy264s3">
<title>UNDERSTANDING TRANSMISSION DYNAMICS</title>
<sec id="kwy264s3a">
<title>Model-data integration for emerging diseases</title>
<p>Mathematical modeling as a means to understanding infectious disease spread dates to studies by Sir Ronald Ross (<xref ref-type="bibr" rid="kwy264C8">8</xref>). Although the use of models to connect data such as age of infection to transmission dynamics of endemic infections has longstanding precedent (<xref ref-type="bibr" rid="kwy264C66">66</xref>, <xref ref-type="bibr" rid="kwy264C67">67</xref>), assimilation of outbreak data for near-term assessments of control priorities is a comparatively recent phenomenon. Integration of modeling with the public health response to epidemics of bovine spongiform encephalopathy and foot-and-mouth disease in the United Kingdom and the severe acute respiratory syndrome epidemic (<xref ref-type="bibr" rid="kwy264C68">68</xref>–<xref ref-type="bibr" rid="kwy264C73">73</xref>) has led to expectations for near real-time modeling studies during major outbreaks. In recent experience, models of the spread of pandemic influenza A H1N1 (<xref ref-type="bibr" rid="kwy264C74">74</xref>), cholera (<xref ref-type="bibr" rid="kwy264C75">75</xref>), Middle East respiratory syndrome (<xref ref-type="bibr" rid="kwy264C76">76</xref>), EBOV (<xref ref-type="bibr" rid="kwy264C77">77</xref>, <xref ref-type="bibr" rid="kwy264C78">78</xref>), Chikungunya virus (<xref ref-type="bibr" rid="kwy264C79">79</xref>), Zika virus (<xref ref-type="bibr" rid="kwy264C80">80</xref>, <xref ref-type="bibr" rid="kwy264C81">81</xref>), yellow fever (<xref ref-type="bibr" rid="kwy264C82">82</xref>), and plague (<xref ref-type="bibr" rid="kwy264C83">83</xref>) have all been published within weeks of the respective outbreak notifications.</p>
<p>Although the circumstances of particular epidemics dictate what data may be available and pertinent, methods for fitting models to data have generally focused on exponential growth rates in cases (<xref ref-type="bibr" rid="kwy264C84">84</xref>) or the distribution of the serial interval (<xref ref-type="bibr" rid="kwy264C85">85</xref>). Methods based on the latter class of data offer the advantage of illustrating real-time changes in reproductive numbers (<xref ref-type="bibr" rid="kwy264C86">86</xref>); however, the requisite information from patient line lists is seldom available. Reliance instead on ecological data exposes models to numerous vulnerabilities, notably the inability to discern individual risk factors (and thus the population meaningfully at risk). These shortcomings may prevent models from predicting reductions in transmission before depletion of the susceptible population.</p>
<p>A challenge thus lies ahead in determining the role of models in outbreak response and the best practices for communicating modeling results. Although the ability of models to evaluate prophylactic strategies may be considered a benefit, recommendations to act against remote future risks have sometimes triggered resistance among stakeholders (<xref ref-type="bibr" rid="kwy264C87">87</xref>). During the West African EBOV epidemic, for example, attention to worst-case model-based projections prompted some to question the reliability of the models (<xref ref-type="bibr" rid="kwy264C88">88</xref>), reflecting an important discrepancy between public understanding of modeling as a forecasting tool and the intended uses of models for scenario-based comparisons (<xref ref-type="bibr" rid="kwy264C89">89</xref>, <xref ref-type="bibr" rid="kwy264C90">90</xref>). This use of modeling has been better understood in attempts to communicate the impact of interventions after the fact (<xref ref-type="bibr" rid="kwy264C91">91</xref>).</p>
</sec>
<sec id="kwy264s3b">
<title>Microbial sequencing</title>
<p>The ease of sequencing pathogen genomes has afforded a new view into transmission during outbreaks. Use of sequence data to identify transmission clusters in the presence of unsure epidemiologic links dates to the early years of the human immunodeficiency virus and acquired immunodeficiency syndrome epidemic (<xref ref-type="bibr" rid="kwy264C92">92</xref>). In recent years, sequencing has aided efforts to track the sources of unexplained epidemics of cholera in Haiti (<xref ref-type="bibr" rid="kwy264C93">93</xref>) and EBOV in West Africa (<xref ref-type="bibr" rid="kwy264C94">94</xref>), and has shown increasing utility for reconstructing the geographic spread of pathogens (<xref ref-type="bibr" rid="kwy264C95">95</xref>, <xref ref-type="bibr" rid="kwy264C96">96</xref>). A particular advantage of phylogenetic analysis is the possibility of estimating unobserved epidemiologic quantities, such as the reporting fraction (<xref ref-type="bibr" rid="kwy264C97">97</xref>) and reproductive numbers for subcritical transmission (<xref ref-type="bibr" rid="kwy264C98">98</xref>), which remain difficult to assess from traditional case-notification data.</p>
<p>Beyond reconstructing the demographic history of pathogen lineages, recent years have seen progress toward joint analysis of epidemiologic and sequencing data (<xref ref-type="bibr" rid="kwy264C99">99</xref>). Such “phylodynamic” approaches have shown particular relevance for emerging infections, including distinguishing the role of repeated introductions and subsequent local transmission (<xref ref-type="bibr" rid="kwy264C100">100</xref>–<xref ref-type="bibr" rid="kwy264C103">103</xref>). Whereas most applications have been tailored to specific data sets and assumptions, the development of generalized methods for joint inference of epidemiologic and phylogenetic parameters remains a priority (<xref ref-type="bibr" rid="kwy264C104">104</xref>) to support real-time analysis.</p>
</sec>
</sec>
<sec id="kwy264s4">
<title>EVALUATION OF INFECTIOUS DISEASE INTERVENTIONS</title>
<sec id="kwy264s4a">
<title>Efficacy evaluations in emergencies</title>
<p>The ability to rapidly develop and deploy countermeasures to mitigate the threat posed by emerging infections has received increasing recognition as a component of public health preparedness. However, outbreaks are difficult environments in which to evaluate interventions. During the West African EBOV epidemic, the feasibility of a new paradigm for development and evaluation of interventions in emergencies was demonstrated by accelerated vaccine safety, immunogenicity, and efficacy studies(<xref ref-type="bibr" rid="kwy264C105">105</xref>). The Coalition for Epidemic Preparedness Innovations was established in 2017, with an initial focus on vaccines against Nipah virus, Middle East respiratory syndrome coronavirus, and Lassa fever virus, in addition to adaptable vaccine platforms for novel threats (<xref ref-type="bibr" rid="kwy264C106">106</xref>).</p>
<p>Lessons learned in EBOV vaccine trials will have an influential bearing on evaluations during future emergencies. Despite efforts to accelerate evaluation of candidate vaccines, incidence had reached low levels by the time phase III efficacy trials were ready to begin, posing a threat to their statistical power: A planned trial in Liberia was canceled due to declining transmission (<xref ref-type="bibr" rid="kwy264C107">107</xref>), and no cases of disease occurred in a second trial in Sierra Leone (<xref ref-type="bibr" rid="kwy264C108">108</xref>), preventing efficacy assessments. In a stepped-wedge trial in Guinea, clusters of primary and secondary contacts of EBOV disease cases were randomly assigned to immediate or delayed vaccination; no cases were reported among vaccine recipients during the trial (<xref ref-type="bibr" rid="kwy264C109">109</xref>) or in subsequent field deployments of the vaccine, supporting a conclusion of near 100% vaccine efficacy.</p>
<p>Debates surrounding design of these trials highlight methodological questions requiring additional attention. In the Guinean trial, a “ring” vaccination scheme helped maximize power by enrolling contacts of known cases (<xref ref-type="bibr" rid="kwy264C110">110</xref>). However, the choice of individual- or cluster-level randomization within rings was debated. Because members of a vaccinated cluster are exposed to direct protection through vaccination and indirect protection due to reduced transmission within their clusters (<xref ref-type="bibr" rid="kwy264C28">28</xref>), cluster-randomized trials have weaker statistical power than individually randomized trials of the same size (<xref ref-type="bibr" rid="kwy264C111">111</xref>). Moreover, the direct effect measured in individually randomized studies may be a preferred, transportable efficacy measure (<xref ref-type="bibr" rid="kwy264C112">112</xref>). Uses of simulation helped in planning vaccine trials tailored to the real-world circumstances of the EBOV outbreak (<xref ref-type="bibr" rid="kwy264C113">113</xref>) and enabled trialists to compare alternative designs in terms of ethical mandates (<xref ref-type="bibr" rid="kwy264C114">114</xref>). Simulation-guided design further presents the opportunity for applying adaptive trial methods (<xref ref-type="bibr" rid="kwy264C115">115</xref>) in the context of infectious disease outbreaks, where dynamic trends in incidence may highlight the benefits of such approaches.</p>
</sec>
<sec id="kwy264s4b">
<title>Observational designs</title>
<p>In addition to efficacy trials for new interventions, observational studies are needed to assess licensed interventions against evolving and re-emerging pathogens. Most commonly applied in evaluations of influenza vaccines, test-negative designs have become popular in routine (<xref ref-type="bibr" rid="kwy264C116">116</xref>) and exploratory (<xref ref-type="bibr" rid="kwy264C117">117</xref>) studies of vaccine effectiveness. By measuring vaccine effectiveness from the exposure odds ratio of vaccination among individuals seeking care who test positive or negative for a pathogen of interest, this design seeks to overcome associations of health-care seeking with vaccination status (<xref ref-type="bibr" rid="kwy264C118">118</xref>). However, it is uncertain whether health-care seeking and other sources of confounding are appropriately controlled for, and whether measures accurately capture vaccine direct effects (<xref ref-type="bibr" rid="kwy264C119">119</xref>, <xref ref-type="bibr" rid="kwy264C120">120</xref>). Uncertainty about the validity of estimates that routinely inform vaccine policy-making demonstrates the need for formal evaluations of such studies and strategies to reduce bias.</p>
<p>Time series analyses of public health surveillance data provide another approach to measuring the real-world impact of vaccination on disease incidence, with the advantage of identifying the overall effect of a vaccination program resulting from direct and indirect protection (<xref ref-type="bibr" rid="kwy264C28">28</xref>). Although the ecological nature of such designs permits the introduction of biases from changes in diagnostic practices or health-care seeking, such studies nonetheless have offered important insights where other approaches failed. Limited reductions in influenza-related deaths among elderly persons amid increases in influenza vaccine coverage during the 1990s provided an important indication that the “healthy vaccinee” effect accounted for astonishing and implausible protection against all-cause mortality among elderly influenza vaccine recipients in cohort and case-control studies (<xref ref-type="bibr" rid="kwy264C121">121</xref>–<xref ref-type="bibr" rid="kwy264C123">123</xref>). Newer methods continue to improve public health inferences obtained from time-series data. In a recent evaluation of invasive pneumococcal disease incidence, trends expected under continued use of 7-valent pneumococcal conjugate vaccine provided a counterfactual condition for measuring the impact of the switch to a 13-valent vaccine targeting emerging serotypes (<xref ref-type="bibr" rid="kwy264C124">124</xref>). Bayesian averaging of models encoding differing pre- and postvaccination trends and change points provides a generalized strategy for defining such counterfactual comparisons (<xref ref-type="bibr" rid="kwy264C125">125</xref>). Other signals of transmission intensity in surveillance data, such as age of infection and sub- or multiannual periodicity, may provide additional insights while reducing sensitivity to fluctuations in reporting effort (<xref ref-type="bibr" rid="kwy264C126">126</xref>, <xref ref-type="bibr" rid="kwy264C127">127</xref>).</p>
<p>The re-emergence of pathogens against which vaccines are widely deployed, such as varicella, pertussis, and mumps in the United States, poses additional challenges for conducting vaccine effectiveness studies. Situational factors may undermine researchers’ ability to establish the extent to which cases owe to primary or secondary vaccine failure in all or certain vaccine recipients, and whether emerging pathogen lineages are escaping vaccine-driven immune pressure. For instance, high compliance with vaccine schedules may limit variation in individuals’ vaccination status and exposures, necessitating large samples to detect factors influencing vaccine performance (<xref ref-type="bibr" rid="kwy264C128">128</xref>). Because re-emergence most likely reflects the expansion of 1 or several pathogen clades, limited pathogen diversity may hinder the application of conventional approaches to identifying microbial determinants of vaccine escape (<xref ref-type="bibr" rid="kwy264C129">129</xref>, <xref ref-type="bibr" rid="kwy264C130">130</xref>). Novel methods to distinguish null from vaccine-driven mutations in antigen-coding regions (<xref ref-type="bibr" rid="kwy264C102">102</xref>, <xref ref-type="bibr" rid="kwy264C131">131</xref>) may streamline efforts to identify vaccine escape, while mathematical modeling provides a basis for comparing candidate hypotheses with observations (<xref ref-type="bibr" rid="kwy264C26">26</xref>, <xref ref-type="bibr" rid="kwy264C27">27</xref>).</p>
</sec>
<sec id="kwy264s4c">
<title>Vaccine safety</title>
<p>Because vaccine studies are typically powered for primary clinical endpoints, long-term observational studies are needed to monitor for rare vaccine-attributable adverse events. Such studies have been crucial to identifying safety concerns such as intussusception after rotavirus vaccination (<xref ref-type="bibr" rid="kwy264C132">132</xref>) and to refuting spurious links, such as autism onset after measles-mumps-rubella vaccination (<xref ref-type="bibr" rid="kwy264C133">133</xref>). However, unique challenges arise in vaccine safety studies; at the individual level, vaccination and adverse-event detection may be confounded due to health-care–seeking behavior, whereas at the population level, age-related confounding may occur when vaccine recommendations are based on the individual’s age.</p>
<p>Ecological designs taking advantage of natural experiments have proven useful in numerous studies of vaccine safety (<xref ref-type="bibr" rid="kwy264C134">134</xref>, <xref ref-type="bibr" rid="kwy264C135">135</xref>) but inconclusive for certain classes of rare events, including those that also result from the vaccine-targeted infection (<xref ref-type="bibr" rid="kwy264C136">136</xref>, <xref ref-type="bibr" rid="kwy264C137">137</xref>). Recent years have seen growing interest in case-only methods offering the ability to reduce or rule out individual-level sources of confounding. Case-crossover methods are common among such approaches (<xref ref-type="bibr" rid="kwy264C138">138</xref>, <xref ref-type="bibr" rid="kwy264C139">139</xref>) and resemble matched case-control studies by sampling “control” periods from the person-time contributed by case individuals before an adverse event. Self-controlled case-series methods similarly benefit from the use of cases as their own controls, following a cohort logic in estimating the relative incidence of adverse events after vaccination within specified risk periods (<xref ref-type="bibr" rid="kwy264C140">140</xref>); with adequate sample size, researchers may be able to use such analyses to eliminate or greatly reduce potential time- or age-related confounding.</p>
</sec>
<sec id="kwy264s4d">
<title>Antimicrobial drugs</title>
<p>In response to the growing threat posed by antimicrobial resistance, the World Health Organization and national governments have prioritized bringing novel antimicrobial drugs to market (<xref ref-type="bibr" rid="kwy264C141">141</xref>). These plans will necessitate phase III trials in which the efficacy of new therapeutic agents is addressed and possibly phase IV studies, in which the optimal use of new and existing drugs, either singly or in combination, can be determined. Whereas patients traditionally have been enrolled in antimicrobial treatment studies on the basis of target bacterial species infections or clinical syndromes, it is uncertain within what strata such trials may yield transportable inferences. Rather than merely the infecting pathogen’s baseline resistance or susceptibility phenotype, strata may be defined by factors such as pathogen lineage, mutational barriers to resistance development (<xref ref-type="bibr" rid="kwy264C142">142</xref>), and presence of horizontally transferable resistance elements in cocolonizing agents or environmental sources (<xref ref-type="bibr" rid="kwy264C143">143</xref>). Stratification based on interpatient and even intrapatient tumor heterogeneity is an emerging feature of cancer therapy trials and may provide a template for such designs (<xref ref-type="bibr" rid="kwy264C144">144</xref>).</p>
<p>In addition to clinical endpoints, carriage of susceptible and resistant bacteria, including commensal agents not purposefully targeted by treatment, can inform the impact of treatment on resistance selection in targeted and bystander species (<xref ref-type="bibr" rid="kwy264C145">145</xref>). Whereas between-group differences in the absolute prevalence of colonization with resistant organisms (<xref ref-type="bibr" rid="kwy264C146">146</xref>) are tested for routinely, stratified measurements (see the reports of Shrag et al. (<xref ref-type="bibr" rid="kwy264C147">147</xref>) and Feikin et al. (<xref ref-type="bibr" rid="kwy264C148">148</xref>), for example) of the effect of treatment on acquisition and clearance of susceptible and resistant pathogens are more informative of the underlying biology (<xref ref-type="bibr" rid="kwy264C149">149</xref>) and may detect signals of selection masked by simpler between-group comparisons (<xref ref-type="bibr" rid="kwy264C150">150</xref>, <xref ref-type="bibr" rid="kwy264C151">151</xref>).</p>
<p>Studies are also needed to address optimal deployment of new and existing antimicrobial drugs in clinical practice. The tradeoff between maximizing a drug’s impact and minimizing resistance selection has led policymakers to ration certain new drugs as last-resort treatments. However, in recent experience, such decisions have ignited ethical debates (<xref ref-type="bibr" rid="kwy264C152">152</xref>). Coupling mathematical modeling with field-based studies has proven useful for understanding the effectiveness of antimicrobial use policies, as highlighted in recent evaluations of the risk of resistance under population-wide access of the tuberculosis drug bedaquiline (<xref ref-type="bibr" rid="kwy264C153">153</xref>, <xref ref-type="bibr" rid="kwy264C154">154</xref>) and antimicrobial cycling to limit resistance selection in hospital settings (<xref ref-type="bibr" rid="kwy264C155">155</xref>, <xref ref-type="bibr" rid="kwy264C156">156</xref>).</p>
</sec>
</sec>
<sec id="kwy264s5">
<title>ETIOLOGIC UNDERSTANDING</title>
<p>Whereas certain efforts we have discussed have been made to identify novel microorganisms able to cause human infection (<xref ref-type="bibr" rid="kwy264C40">40</xref>, <xref ref-type="bibr" rid="kwy264C157">157</xref>), most epidemics caused by emerging pathogens have been recognized first by clusters of anomalous syndromes—such as cardiopulmonary syndrome caused by New World hantaviruses, severe acute respiratory syndrome caused by a coronavirus, and congenital abnormalities caused by Zika virus —before the role or even existence of the etiologic microorganism had been characterized. The problem of ascribing a clinical syndrome to an etiologic agent is among the oldest in epidemiology, dating at least to the 19th century, when Robert Koch laid out criteria for such inference (i.e., Koch’s, or more correctly, Henle-Koch’s, postulates (<xref ref-type="bibr" rid="kwy264C158">158</xref>)). However, these postulates have long been recognized as inadequate, particularly for illnesses caused by viruses, and thus of largely historical interest (<xref ref-type="bibr" rid="kwy264C159">159</xref>); for instance, the notion that a pathogen should be absent from healthy individuals is incompatible with the prominence of carriage and asymptomatic infection in the natural history of numerous pathogens. A growing appreciation of the complexity of the human microbiome, and the likelihood that intricate mixtures of microorganisms at diverse body sites may be either the cause or consequence of both detrimental and beneficial physiological states, has further highlighted the difficulty of linking a given health outcome to infection by a single microorganism.</p>
<p>The now-recognized critically important role of persistent infection and the inflammation it can produce in diverse cancers and possibly other chronic diseases has further diminished the relevance of Koch’s postulates and the age-old distinction between infectious and chronic diseases, as illustrated in the well-known example of human papillomavirus causing cervical, anal, and oral cancers (<xref ref-type="bibr" rid="kwy264C160">160</xref>). The best causal understanding of such relationships has come from randomized trials demonstrating that infection-preventing interventions are efficacious against downstream chronic illness, such as peptic ulcers due to <italic>Helicobacter pylori</italic> and chronic wheeze due to respiratory syncytial virus (<xref ref-type="bibr" rid="kwy264C161">161</xref>, <xref ref-type="bibr" rid="kwy264C162">162</xref>). Natural experiments following the same intuition have provided additional evidence of such relationships, such as measles-induced immunosuppression (<xref ref-type="bibr" rid="kwy264C163">163</xref>), malnutrition and stunting due to enteric infection (<xref ref-type="bibr" rid="kwy264C164">164</xref>), and complex or chronic otitis media due to tissue damage from acute early-life disease (<xref ref-type="bibr" rid="kwy264C165">165</xref>). Such relationships have proven difficult to probe in the absence of a randomized or natural experiment, because of the likelihood that confounding factors influence individuals’ risk for initial infection as well as chronic sequelae. New paradigms for ascribing an etiologic role to microorganisms and resulting host responses are clearly needed and may prove important in efforts to quantify the health impacts of infectious disease interventions.</p>
</sec>
<sec id="kwy264s6">
<title>SUMMARY</title>
<p>The recognition in the 1970s and 1980s that infectious diseases were not, in fact, disappearing as important causes of morbidity and mortality in human populations has been followed by renewed interest in these conditions, especially in the emergence or re-emergence of diverse infectious diseases and in the role of infection in various chronic diseases. At the same time, advances in epidemiologic and statistical methods, together with the growing availability of data from diverse sources, have provided new tools and approaches for studying infectious diseases. The infectious disease epidemiologists of the future will need a solid grounding in the biology of infection and the host immune response, as well as training in the increasingly sophisticated approaches to causal inference; the manipulation and analysis of large-scale data sets, including pathogen genome sequences; and mathematical modeling, together with the behavioral and social determinants of health. Integration of these elements into epidemiology training programs (e.g., through coursework in Bayesian statistics and phylogenetics) represents an increasingly important consideration for academic departments.</p>
</sec>
</body>
<back>
<ack id="kwy264ack1">
<title>ACKNOWLEDGMENTS</title>
<p>Authors’ affiliations: Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, California (Joseph A. Lewnard, Arthur L. Reingold).</p>
<p>The authors received no specific funding for this article.</p>
<p>Conflict of interest: none declared.</p>
</ack>
<glossary>
<title>Abbreviation</title>
<def-list list-content="abbreviation">
<def-item>
<term id="term1">EBOV</term>
<def>
<p>Ebola virus</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list id="kwy264ref1">
<title>REFERENCES</title>
<ref id="kwy264C1">
<label>1</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Panum</surname><given-names>PL</given-names></name></person-group>
<chapter-title>Observations made during the epidemic of measles on the Faroe Islands in the year 1846</chapter-title> In: <source/>The Challenge of Epidemiology: Issues and Selected Readings. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Pan American Health Organization</publisher-name>; <year>1988</year>:<fpage>37</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C2">
<label>2</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Snow</surname><given-names>J</given-names></name></person-group>
<source/>On the Mode of Communication of Cholera. <publisher-loc>London, United Kingdom</publisher-loc>: <publisher-name>John Churchill</publisher-name>; <year>1855</year>.</mixed-citation>
</ref>
<ref id="kwy264C3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>XXXIII</collab></person-group>
<article-title>The experimental production of plague epidemics among animals</article-title>. <source/>J Hyg (Lond). <year>1910</year>; <volume>10</volume>(<issue>3</issue>):<fpage>315</fpage>–<lpage>334</lpage>.<pub-id pub-id-type="pmid">20474424</pub-id></mixed-citation>
</ref>
<ref id="kwy264C4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Budd</surname><given-names>W</given-names></name></person-group>
<article-title>Typhoid fever: its nature, mode of spreading, and prevention</article-title>. <source/>Am J Public Health (N Y). <year>1918</year>;<volume>8</volume>(<issue>8</issue>):<fpage>610</fpage>–<lpage>612</lpage>.<pub-id pub-id-type="pmid">18009937</pub-id></mixed-citation>
</ref>
<ref id="kwy264C5">
<label>5</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>R</given-names></name></person-group>
<source/>The Prevention of Malaria. <publisher-loc>London, United Kingdom</publisher-loc>: <publisher-name>John Murray</publisher-name>; <year>1911</year>.</mixed-citation>
</ref>
<ref id="kwy264C6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Caroll</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Agramonte</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>The etiology of yellow fever—a preliminary note</article-title>. <source/>Public Health Pap Rep. <year>1900</year>;<volume>26</volume>:<fpage>37</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">19600960</pub-id></mixed-citation>
</ref>
<ref id="kwy264C7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kuh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ben-Shlomo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Life course epidemiology</article-title>. <source/>J Epidemiol Community Health. <year>2003</year>;<volume>57</volume>(<issue>10</issue>):<fpage>778</fpage>–<lpage>783</lpage>.<pub-id pub-id-type="pmid">14573579</pub-id></mixed-citation>
</ref>
<ref id="kwy264C8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>R</given-names></name></person-group>
<article-title>Some <italic>a priori</italic> pathometric equations</article-title>. <source/>Br Med J. <year>1915</year>;<volume>1</volume>(<issue>2830</issue>):<fpage>546</fpage>–<lpage>547</lpage>.<pub-id pub-id-type="pmid">20767555</pub-id></mixed-citation>
</ref>
<ref id="kwy264C9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kermack</surname><given-names>WO</given-names></name>, <name name-style="western"><surname>McKendrick</surname><given-names>AG</given-names></name></person-group>
<article-title>A contribution to the mathematical theory of epidemics</article-title>. <source/>Proc R Soc Lond A Math Phys Sci. <year>1927</year>;<volume>115</volume>(<issue>772</issue>):<fpage>700</fpage>–<lpage>721</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Greenwood</surname><given-names>M</given-names></name></person-group>
<article-title>On the statistical measure of infectiousness</article-title>. <source/>J Hyg (Lond). <year>1931</year>;<volume>31</volume>(<issue>3</issue>):<fpage>336</fpage>–<lpage>351</lpage>.<pub-id pub-id-type="pmid">20475096</pub-id></mixed-citation>
</ref>
<ref id="kwy264C11">
<label>11</label>
<mixed-citation publication-type="journal">
<article-title>Epidemics and crowd-diseases: measles. By Major Greenwood, 1935</article-title>. <source/>Rev Infect Dis. <year>1988</year>;<volume>10</volume>(<issue>2</issue>):<fpage>492</fpage>–<lpage>499</lpage>.<pub-id pub-id-type="pmid">3287571</pub-id></mixed-citation>
</ref>
<ref id="kwy264C12">
<label>12</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>DR</given-names></name></person-group>
<chapter-title>Regression models and life-tables</chapter-title> In: <source/>Breakthroughs in Statistics. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>1992</year>:<fpage>527</fpage>–<lpage>541</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C13">
<label>13</label>
<mixed-citation publication-type="journal">
<article-title>The controlled therapeutic trial</article-title>. <source/>Br Med J. <year>1948</year>;<volume>2</volume>(<issue>4582</issue>):<fpage>791</fpage>–<lpage>792</lpage>.<pub-id pub-id-type="pmid">20787429</pub-id></mixed-citation>
</ref>
<ref id="kwy264C14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Box</surname><given-names>GEP</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>DR</given-names></name></person-group>
<article-title>An analysis of transformations</article-title>. <source/>J R Stat Soc Series B Stat Methodol. <year>1964</year>;<volume>26</volume>(<issue>2</issue>):<fpage>211</fpage>–<lpage>252</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Morse</surname><given-names>SS</given-names></name></person-group>
<article-title>Factors in the emergence of infectious diseases</article-title>. <source/>Emerg Infect Dis. <year>1995</year>;<volume>1</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">8903148</pub-id></mixed-citation>
</ref>
<ref id="kwy264C16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stanaway</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Shepard</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Undurraga</surname><given-names>EA</given-names></name>, <etal>et al</etal></person-group>
<article-title>The global burden of dengue: an analysis from the Global Burden of Disease Study 2013</article-title>. <source/>Lancet Infect Dis. <year>2016</year>;<volume>16</volume>(<issue>6</issue>):<fpage>712</fpage>–<lpage>723</lpage>.<pub-id pub-id-type="pmid">26874619</pub-id></mixed-citation>
</ref>
<ref id="kwy264C17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Lopez</surname><given-names>AL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Updated global burden of cholera in endemic countries</article-title>. <source/>PLoS Negl Trop Dis. <year>2015</year>;<volume>9</volume>(<issue>6</issue>):<fpage>e0003832</fpage>.<pub-id pub-id-type="pmid">26043000</pub-id></mixed-citation>
</ref>
<ref id="kwy264C18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Abeel</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Manson McGuire</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of <italic>Mycobacterium tuberculosis</italic> isolates from KwaZulu-Natal</article-title>. <source/>PLoS Med. <year>2015</year>;<volume>12</volume>(<issue>9</issue>):<fpage>e1001880</fpage>.<pub-id pub-id-type="pmid">26418737</pub-id></mixed-citation>
</ref>
<ref id="kwy264C19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Klemm</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Shakoor</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Page</surname><given-names>AJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Emergence of an extensively drug-resistant <italic>Salmonella enterica</italic> serovar <italic>Typhi</italic> clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins</article-title>. <source/>MBio. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>e00105</fpage>–<lpage>e00118</lpage>.<pub-id pub-id-type="pmid">29463654</pub-id></mixed-citation>
</ref>
<ref id="kwy264C20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ashley</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Dhorda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fairhurst</surname><given-names>RM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Spread of artemisinin resistance in <italic>Plasmodium falciparum</italic> malaria</article-title>. <source/>N Engl J Med. <year>2014</year>;<volume>371</volume>(<issue>5</issue>):<fpage>411</fpage>–<lpage>423</lpage>.<pub-id pub-id-type="pmid">25075834</pub-id></mixed-citation>
</ref>
<ref id="kwy264C21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fifer</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Natarajan</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Failure of dual antimicrobial therapy in treatment of gonorrhea</article-title>. <source/>N Engl J Med. <year>2016</year>;<volume>374</volume>(<issue>25</issue>):<fpage>2504</fpage>–<lpage>2506</lpage>.<pub-id pub-id-type="pmid">27332921</pub-id></mixed-citation>
</ref>
<ref id="kwy264C22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mitjà</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Godornes</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Houinei</surname><given-names>W</given-names></name>, <etal>et al</etal></person-group>
<article-title>Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study</article-title>. <source/>Lancet. <year>2018</year>;<volume>391</volume>(<issue>10130</issue>):<fpage>1599</fpage>–<lpage>1607</lpage>.<pub-id pub-id-type="pmid">29428183</pub-id></mixed-citation>
</ref>
<ref id="kwy264C23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Musicha</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cornick</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Bar-Zeev</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study</article-title>. <source/>Lancet Infect Dis. <year>2017</year>;<volume>17</volume>(<issue>10</issue>):<fpage>1042</fpage>–<lpage>1052</lpage>.<pub-id pub-id-type="pmid">28818544</pub-id></mixed-citation>
</ref>
<ref id="kwy264C24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Filia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bella</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Del Manso</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017—what is making elimination so difficult?</article-title>
<source/>Euro Surveill. <year>2017</year>;<volume>22</volume>(<issue>37</issue>):<fpage>30614</fpage>.<pub-id pub-id-type="pmid">28933342</pub-id></mixed-citation>
</ref>
<ref id="kwy264C25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>AD</given-names></name></person-group>
<article-title>Yellow fever in Angola and beyond—the problem of vaccine supply and demand</article-title>. <source/>N Engl J Med. <year>2016</year>;<volume>375</volume>(<issue>4</issue>):<fpage>301</fpage>–<lpage>303</lpage>.<pub-id pub-id-type="pmid">27276108</pub-id></mixed-citation>
</ref>
<ref id="kwy264C26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lewnard</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Grad</surname><given-names>YH</given-names></name></person-group>
<article-title>Vaccine waning and mumps re-emergence in the United States</article-title>. <source/>Sci Transl Med. <year>2018</year>;<volume>10</volume>(<issue>433</issue>):<fpage>eaao5945</fpage>.<pub-id pub-id-type="pmid">29563321</pub-id></mixed-citation>
</ref>
<ref id="kwy264C27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Domenech de Cellès</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Magpantay</surname><given-names>FMG</given-names></name>, <name name-style="western"><surname>King</surname><given-names>AA</given-names></name>, <etal>et al</etal></person-group>
<article-title>The impact of past vaccination coverage and immunity on pertussis resurgence</article-title>. <source/>Sci Transl Med. <year>2018</year>;<volume>10</volume>(<issue>434</issue>):<fpage>eaaj1748</fpage>.<pub-id pub-id-type="pmid">29593103</pub-id></mixed-citation>
</ref>
<ref id="kwy264C28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Halloran</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Haber</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Longini</surname><given-names>IM</given-names><suffix>Jr</suffix></name>, <etal>et al</etal></person-group>
<article-title>Direct and indirect effects in vaccine efficacy and effectiveness</article-title>. <source/>Am J Epidemiol. <year>1991</year>;<volume>133</volume>(<issue>4</issue>):<fpage>323</fpage>–<lpage>331</lpage>.<pub-id pub-id-type="pmid">1899778</pub-id></mixed-citation>
</ref>
<ref id="kwy264C29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>May</surname><given-names>RM</given-names></name></person-group>
<article-title>Population biology of infectious diseases: Part I</article-title>. <source/>Nature. <year>1979</year>;<volume>280</volume>(<issue>5721</issue>):<fpage>361</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">460412</pub-id></mixed-citation>
</ref>
<ref id="kwy264C30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>May</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name></person-group>
<article-title>Population biology of infectious diseases: Part II</article-title>. <source/>Nature. <year>1979</year>;<volume>280</volume>(<issue>5722</issue>):<fpage>455</fpage>–<lpage>461</lpage>.<pub-id pub-id-type="pmid">460424</pub-id></mixed-citation>
</ref>
<ref id="kwy264C31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Heesterbeek</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Andreasen</surname><given-names>V</given-names></name>, <etal>et al</etal></person-group>
<article-title>Modeling infectious disease dynamics in the complex landscape of global health</article-title>. <source/>Science. <year>2015</year>;<volume>347</volume>(<issue>6227</issue>):<fpage>aaa4339</fpage>.<pub-id pub-id-type="pmid">25766240</pub-id></mixed-citation>
</ref>
<ref id="kwy264C32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bouckaert</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Heled</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kühnert</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>BEAST 2: a software platform for Bayesian evolutionary analysis</article-title>. <source/>PLoS Comput Biol. <year>2014</year>;<volume>10</volume>(<issue>4</issue>):<fpage>e1003537</fpage>.<pub-id pub-id-type="pmid">24722319</pub-id></mixed-citation>
</ref>
<ref id="kwy264C33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kao</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Haydon</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Lycett</surname><given-names>SJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Supersize me: how whole-genome sequencing and big data are transforming epidemiology</article-title>. <source/>Trends Microbiol. <year>2014</year>;<volume>22</volume>(<issue>5</issue>):<fpage>282</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">24661923</pub-id></mixed-citation>
</ref>
<ref id="kwy264C34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Langmuir</surname><given-names>AD</given-names></name></person-group>
<article-title>The surveillance of communicable diseases of national importance</article-title>. <source/>N Engl J Med. <year>1963</year>;<volume>268</volume>:<fpage>182</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">13928666</pub-id></mixed-citation>
</ref>
<ref id="kwy264C35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Glynn</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Groseclose</surname><given-names>SL</given-names></name></person-group>
<article-title>Completeness of notifiable infectious disease reporting in the United States: an analytical literature review</article-title>. <source/>Am J Epidemiol. <year>2002</year>;<volume>155</volume>(<issue>9</issue>):<fpage>866</fpage>–<lpage>874</lpage>.<pub-id pub-id-type="pmid">11978592</pub-id></mixed-citation>
</ref>
<ref id="kwy264C36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tappero</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Cassell</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Bunnell</surname><given-names>RE</given-names></name>, <etal>et al</etal></person-group>
<article-title>US Centers for Disease Control and Prevention and its partners’ contributions to global health security</article-title>. <source/>Emerg Infect Dis. <year>2017</year>;<volume>23</volume>(<issue>13</issue>).</mixed-citation>
</ref>
<ref id="kwy264C37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Whitney</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Pilishvili</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Farley</surname><given-names>MM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study</article-title>. <source/>Lancet. <year>2006</year>;<volume>368</volume>(<issue>9546</issue>):<fpage>1495</fpage>–<lpage>1502</lpage>.<pub-id pub-id-type="pmid">17071283</pub-id></mixed-citation>
</ref>
<ref id="kwy264C38">
<label>38</label>
<mixed-citation publication-type="other">
<person-group person-group-type="author"><collab>US Agency for International Development</collab></person-group> Emerging Pandemic Threats Program. <uri xlink:href="https://www.usaid.gov/ept2">https://www.usaid.gov/ept2</uri>. Accessed July 30, 2018.</mixed-citation>
</ref>
<ref id="kwy264C39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Paez-Espino</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Eloe-Fadrosh</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Pavlopoulos</surname><given-names>GA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Uncovering Earth’s virome</article-title>. <source/>Nature. <year>2016</year>;<volume>536</volume>(<issue>7617</issue>):<fpage>425</fpage>–<lpage>430</lpage>.<pub-id pub-id-type="pmid">27533034</pub-id></mixed-citation>
</ref>
<ref id="kwy264C40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Carroll</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Daszak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wolfe</surname><given-names>ND</given-names></name>, <etal>et al</etal></person-group>
<article-title>The Global Virome Project</article-title>. <source/>Science. <year>2018</year>;<volume>359</volume>(<issue>6378</issue>):<fpage>872</fpage>–<lpage>874</lpage>.<pub-id pub-id-type="pmid">29472471</pub-id></mixed-citation>
</ref>
<ref id="kwy264C41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Holmes</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>KG</given-names></name></person-group>
<article-title>Pandemics: spend on surveillance, not prediction</article-title>. <source/>Nature. <year>2018</year>;<volume>558</volume>(<issue>7709</issue>):<fpage>180</fpage>–<lpage>182</lpage>.<pub-id pub-id-type="pmid">29880819</pub-id></mixed-citation>
</ref>
<ref id="kwy264C42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>NG</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>MA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Global trends in emerging infectious diseases</article-title>. <source/>Nature. <year>2008</year>;<volume>451</volume>(<issue>7181</issue>):<fpage>990</fpage>–<lpage>993</lpage>.<pub-id pub-id-type="pmid">18288193</pub-id></mixed-citation>
</ref>
<ref id="kwy264C43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gardy</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Loman</surname><given-names>NJ</given-names></name></person-group>
<article-title>Towards a genomics-informed, real-time, global pathogen surveillance system</article-title>. <source/>Nat Rev Genet. <year>2018</year>;<volume>19</volume>:<fpage>9</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">29129921</pub-id></mixed-citation>
</ref>
<ref id="kwy264C44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lewnard</surname><given-names>JA</given-names></name></person-group>
<article-title>Ebola virus disease: 11,323 deaths later, how far have we come?</article-title><source/>Lancet. <year>2018</year>;<volume>392</volume>(<issue>10143</issue>):<fpage>189</fpage>–<lpage>190</lpage>.<pub-id pub-id-type="pmid">30047373</pub-id></mixed-citation>
</ref>
<ref id="kwy264C45">
<label>45</label>
<mixed-citation publication-type="other">
<person-group person-group-type="author"><collab>World Health Organization Regional Office for Africa</collab></person-group> Ebola virus disease, Democratic Republic of the Congo: External situation report 9. <uri xlink:href="http://apps.who.int/iris/bitstream/handle/10665/275330/SITREP_EVD_DRC_20181004-eng.pdf?ua=1">http://apps.who.int/iris/bitstream/handle/10665/275330/SITREP_EVD_DRC_20181004-eng.pdf?ua=1</uri>. Accessed October 8, 2018.</mixed-citation>
</ref>
<ref id="kwy264C46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Metcalf</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Farrar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cutts</surname><given-names>FT</given-names></name>, <etal>et al</etal></person-group>
<article-title>Use of serological surveys to generate key insights into the changing global landscape of infectious disease</article-title>. <source/>Lancet. <year>2016</year>;<volume>388</volume>(<issue>10045</issue>):<fpage>728</fpage>–<lpage>730</lpage>.<pub-id pub-id-type="pmid">27059886</pub-id></mixed-citation>
</ref>
<ref id="kwy264C47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Crozier</surname><given-names>I</given-names></name></person-group>
<article-title>Mapping a filoviral serologic footprint in the Democratic Republic of the Congo: who goes there?</article-title><source/>J Infect Dis. <year>2018</year>;<volume>217</volume>(<issue>4</issue>):<fpage>513</fpage>–<lpage>515</lpage>.<pub-id pub-id-type="pmid">29329413</pub-id></mixed-citation>
</ref>
<ref id="kwy264C48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wikan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>DR</given-names></name></person-group>
<article-title>Zika virus: history of a newly emerging arbovirus</article-title>. <source/>Lancet Infect Dis. <year>2016</year>;<volume>16</volume>(<issue>7</issue>):<fpage>e119</fpage>–<lpage>e126</lpage>.<pub-id pub-id-type="pmid">27282424</pub-id></mixed-citation>
</ref>
<ref id="kwy264C49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Katzelnick</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Gresh</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Halloran</surname><given-names>ME</given-names></name>, <etal>et al</etal></person-group>
<article-title>Antibody-dependent enhancement of severe dengue disease in humans</article-title>. <source/>Science. <year>2017</year>;<volume>358</volume>(<issue>6365</issue>):<fpage>929</fpage>–<lpage>932</lpage>.<pub-id pub-id-type="pmid">29097492</pub-id></mixed-citation>
</ref>
<ref id="kwy264C50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cobey</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hensley</surname><given-names>SE</given-names></name></person-group>
<article-title>Immune history and influenza virus susceptibility</article-title>. <source/>Curr Opin Virol. <year>2017</year>;<volume>22</volume>:<fpage>105</fpage>–<lpage>111</lpage>.<pub-id pub-id-type="pmid">28088686</pub-id></mixed-citation>
</ref>
<ref id="kwy264C51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perdue</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Cost</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Rubertone</surname><given-names>MV</given-names></name>, <etal>et al</etal></person-group>
<article-title>Description and utilization of the United States department of defense serum repository: a review of published studies, 1985–2012</article-title>. <source/>PLoS One. <year>2015</year>;<volume>10</volume>(<issue>2</issue>):<fpage>e0114857</fpage>.<pub-id pub-id-type="pmid">25723497</pub-id></mixed-citation>
</ref>
<ref id="kwy264C52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Madoff</surname><given-names>LC</given-names></name></person-group>
<article-title>ProMED-mail: an early warning system for emerging diseases</article-title>. <source/>Clin Infect Dis. <year>2004</year>;<volume>39</volume>(<issue>2</issue>):<fpage>227</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">15307032</pub-id></mixed-citation>
</ref>
<ref id="kwy264C53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brownstein</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Freifeld</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Reis</surname><given-names>BY</given-names></name>, <etal>et al</etal></person-group>
<article-title>Surveillance Sans Frontières: internet-based emerging infectious disease intelligence and the HealthMap project</article-title>. <source/>PLoS Med. <year>2008</year>;<volume>5</volume>(<issue>7</issue>):<fpage>e151</fpage>.<pub-id pub-id-type="pmid">18613747</pub-id></mixed-citation>
</ref>
<ref id="kwy264C54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brownstein</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Freifeld</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Madoff</surname><given-names>LC</given-names></name></person-group>
<article-title>Digital disease detection—harnessing the Web for public health surveillance</article-title>. <source/>N Engl J Med. <year>2009</year>;<volume>360</volume>(<issue>21</issue>):<fpage>2153</fpage>–<lpage>2155</lpage>, 2157.<pub-id pub-id-type="pmid">19423867</pub-id></mixed-citation>
</ref>
<ref id="kwy264C55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Heffernan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mostashari</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>Syndromic surveillance in public health practice, New York City</article-title>. <source/>Emerg Infect Dis. <year>2004</year>;<volume>10</volume>(<issue>5</issue>):<fpage>858</fpage>–<lpage>864</lpage>.<pub-id pub-id-type="pmid">15200820</pub-id></mixed-citation>
</ref>
<ref id="kwy264C56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reingold</surname><given-names>A</given-names></name></person-group>
<article-title>If syndromic surveillance is the answer, what is the question?</article-title><source/>Biosecur Bioterror. <year>2003</year>;<volume>1</volume>(<issue>2</issue>):<fpage>77</fpage>–<lpage>81</lpage>.<pub-id pub-id-type="pmid">15040185</pub-id></mixed-citation>
</ref>
<ref id="kwy264C57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group>
<article-title>Increased antiviral medication sales before the 2005–06 influenza season—New York City</article-title>. <source/>MMWR Morb Mortal Wkly Rep. <year>2006</year>;<volume>55</volume>(<issue>10</issue>):<fpage>277</fpage>–<lpage>279</lpage>.<pub-id pub-id-type="pmid">16543882</pub-id></mixed-citation>
</ref>
<ref id="kwy264C58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Buckee</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Cardenas</surname><given-names>MIE</given-names></name>, <name name-style="western"><surname>Corpuz</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Productive disruption: opportunities and challenges for innovation in infectious disease surveillance</article-title>. <source/>BMJ Glob Health. <year>2018</year>;<volume>3</volume>(<issue>1</issue>):<fpage>e000538</fpage>.</mixed-citation>
</ref>
<ref id="kwy264C59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chunara</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Andrews</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Brownstein</surname><given-names>JS</given-names></name></person-group>
<article-title>Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak</article-title>. <source/>Am J Trop Med Hyg. <year>2012</year>;<volume>86</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">22232449</pub-id></mixed-citation>
</ref>
<ref id="kwy264C60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leung</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>M</given-names></name></person-group>
<article-title>Vaccination compliance and the US measles epidemic</article-title>. <source/>JAMA Pediatr. <year>2015</year>;<volume>169</volume>(<issue>9</issue>):<fpage>876</fpage>–<lpage>877</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Majumder</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Mekaru</surname><given-names>SR</given-names></name>, <etal>et al</etal></person-group>
<article-title>Substandard vaccination compliance and the 2015 measles outbreak</article-title>. <source/>JAMA Pediatr. <year>2015</year>;<volume>169</volume>(<issue>5</issue>):<fpage>494</fpage>–<lpage>495</lpage>.<pub-id pub-id-type="pmid">25774618</pub-id></mixed-citation>
</ref>
<ref id="kwy264C62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Majumder</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>EL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Vaccine compliance and the 2016 Arkansas mumps outbreak</article-title>. <source/>Lancet Infect Dis. <year>2017</year>;<volume>17</volume>(<issue>4</issue>):<fpage>361</fpage>–<lpage>362</lpage>.<pub-id pub-id-type="pmid">28346168</pub-id></mixed-citation>
</ref>
<ref id="kwy264C63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lazer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>King</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Big data. The parable of Google Flu: traps in big data analysis</article-title>. <source/>Science. <year>2014</year>;<volume>343</volume>(<issue>6176</issue>):<fpage>1203</fpage>–<lpage>1205</lpage>.<pub-id pub-id-type="pmid">24626916</pub-id></mixed-citation>
</ref>
<ref id="kwy264C64">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Farrow</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Hyun</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Flexible modeling of epidemics with an Empirical Bayes framework</article-title>. <source/>PLoS Comput Biol. <year>2015</year>;<volume>11</volume>(<issue>8</issue>):<fpage>e1004382</fpage>.<pub-id pub-id-type="pmid">26317693</pub-id></mixed-citation>
</ref>
<ref id="kwy264C65">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Farrow</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Hyun</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>A human judgment approach to epidemiological forecasting</article-title>. <source/>PLoS Comput Biol. <year>2017</year>;<volume>13</volume>(<issue>3</issue>):<fpage>e1005248</fpage>.<pub-id pub-id-type="pmid">28282375</pub-id></mixed-citation>
</ref>
<ref id="kwy264C66">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fales</surname><given-names>WT</given-names></name></person-group>
<article-title>The age distribution of whooping cough, measles, chicken pox, scarlet fever, and diphtheria in various areas in the United States</article-title>. <source/>Am J Epidemiol. <year>1928</year>;<volume>8</volume>(<issue>5</issue>):<fpage>759</fpage>–<lpage>799</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C67">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Muench</surname><given-names>H</given-names></name></person-group>
<article-title>Derivation of rates from summation data by the catalytic curve</article-title>. <source/>J Am Stat Assoc. <year>1934</year>;<volume>29</volume>(<issue>185</issue>):<fpage>25</fpage>–<lpage>38</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C68">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ferguson</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name></person-group>
<article-title>The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions</article-title>. <source/>Science. <year>2001</year>;<volume>292</volume>(<issue>5519</issue>):<fpage>1155</fpage>–<lpage>1160</lpage>.<pub-id pub-id-type="pmid">11303090</pub-id></mixed-citation>
</ref>
<ref id="kwy264C69">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Woolhouse</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chase-Topping</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Haydon</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>Epidemiology. Foot-and-mouth disease under control in the UK</article-title>. <source/>Nature. <year>2001</year>;<volume>411</volume>(<issue>6835</issue>):<fpage>258</fpage>–<lpage>259</lpage>.</mixed-citation>
</ref>
<ref id="kwy264C70">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ferguson</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name></person-group>
<article-title>Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain</article-title>. <source/>Nature. <year>2001</year>;<volume>413</volume>(<issue>6855</issue>):<fpage>542</fpage>–<lpage>548</lpage>.<pub-id pub-id-type="pmid">11586365</pub-id></mixed-citation>
</ref>
<ref id="kwy264C71">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Ferguson</surname><given-names>NM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Transmission dynamics and epidemiology of BSE in British cattle</article-title>. <source/>Nature. <year>1996</year>;<volume>382</volume>(<issue>6594</issue>):<fpage>779</fpage>–<lpage>788</lpage>.<pub-id pub-id-type="pmid">8752271</pub-id></mixed-citation>
</ref>
<ref id="kwy264C72">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Transmission dynamics and control of severe acute respiratory syndrome</article-title>. <source/>Science. <year>2003</year>;<volume>300</volume>(<issue>5627</issue>):<fpage>1966</fpage>–<lpage>1970</lpage>.<pub-id pub-id-type="pmid">12766207</pub-id></mixed-citation>
</ref>
<ref id="kwy264C73">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions</article-title>. <source/>Science. <year>2003</year>;<volume>300</volume>(<issue>5627</issue>):<fpage>1961</fpage>–<lpage>1966</lpage>.<pub-id pub-id-type="pmid">12766206</pub-id></mixed-citation>
</ref>
<ref id="kwy264C74">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Cauchemez</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Pandemic potential of a strain of influenza A (H1N1): early findings</article-title>. <source/>Science. <year>2009</year>;<volume>324</volume>(<issue>5934</issue>):<fpage>1557</fpage>–<lpage>1561</lpage>.<pub-id pub-id-type="pmid">19433588</pub-id></mixed-citation>
</ref>
<ref id="kwy264C75">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tuite</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Tien</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Eisenberg</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Cholera epidemic in Haiti, 2010: using a transmission model to explain spatial spread of disease and identify optimal control interventions</article-title>. <source/>Ann Intern Med. <year>2011</year>;<volume>154</volume>(<issue>9</issue>):<fpage>593</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">21383314</pub-id></mixed-citation>
</ref>
<ref id="kwy264C76">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Breban</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Riou</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fontanet</surname><given-names>A</given-names></name></person-group>
<article-title>Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk</article-title>. <source/>Lancet. <year>2013</year>;<volume>382</volume>(<issue>9893</issue>):<fpage>694</fpage>–<lpage>699</lpage>.<pub-id pub-id-type="pmid">23831141</pub-id></mixed-citation>
</ref>
<ref id="kwy264C77">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nishiura</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chowell</surname><given-names>G</given-names></name></person-group>
<article-title>Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014</article-title>. <source/>Euro Surveill. <year>2014</year>;<volume>19</volume>(<issue>36</issue>):<fpage>20894</fpage>.<pub-id pub-id-type="pmid">25232919</pub-id></mixed-citation>
</ref>
<ref id="kwy264C78">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Barry</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ahuka-Mundeke</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ali Ahmed</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April–May, 2018: an epidemiological study</article-title>. <source/>Lancet. <year>2018</year>;<volume>392</volume>(<issue>10143</issue>):<fpage>213</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">30047375</pub-id></mixed-citation>
</ref>
<ref id="kwy264C79">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Cauchemez</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ledrans</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Poletto</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Local and regional spread of chikungunya fever in the Americas</article-title>. <source/>Euro Surveill. <year>2014</year>;<volume>19</volume>(<issue>28</issue>):<fpage>20854</fpage>.<pub-id pub-id-type="pmid">25060573</pub-id></mixed-citation>
</ref>
<ref id="kwy264C80">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lessler</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chaisson</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Kucirka</surname><given-names>LM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Assessing the global threat from Zika virus</article-title>. <source/>Science. <year>2016</year>;<volume>353</volume>(<issue>6300</issue>):<fpage>aaf8160</fpage>.<pub-id pub-id-type="pmid">27417495</pub-id></mixed-citation>
</ref>
<ref id="kwy264C81">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ferguson</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Cucunubá</surname><given-names>ZM</given-names></name>, <name name-style="western"><surname>Dorigatti</surname><given-names>I</given-names></name>, <etal>et al</etal></person-group>
<article-title>Countering the Zika epidemic in Latin America</article-title>. <source/>Science. <year>2016</year>;<volume>353</volume>(<issue>6297</issue>):<fpage>353</fpage>–<lpage>354</lpage>.<pub-id pub-id-type="pmid">27417493</pub-id></mixed-citation>
</ref>
<ref id="kwy264C82">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Peak</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>GM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Fractional dosing of yellow fever vaccine to extend supply: a modelling study</article-title>. <source/>Lancet. <year>2016</year>;<volume>388</volume>(<issue>10062</issue>):<fpage>2904</fpage>–<lpage>2911</lpage>.<pub-id pub-id-type="pmid">27837923</pub-id></mixed-citation>
</ref>
<ref id="kwy264C83">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tsuzuki</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Miura</surname><given-names>F</given-names></name>, <etal>et al</etal></person-group>
<article-title>Dynamics of the pneumonic plague epidemic in Madagascar, August to October 2017</article-title>. <source/>Eurosurveill. <year>2017</year>;<volume>22</volume>(<issue>46</issue>).</mixed-citation>
</ref>
<ref id="kwy264C84">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Domenech de Cellès</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Magpantay</surname><given-names>FM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Avoidable errors in the modelling of outbreaks of emerging pathogens, with special reference to Ebola</article-title>. <source/>Proc Biol Sci. <year>2015</year>;<volume>282</volume>(<issue>1806</issue>):<fpage>20150347</fpage>.<pub-id pub-id-type="pmid">25833863</pub-id></mixed-citation>
</ref>
<ref id="kwy264C85">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wallinga</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name></person-group>
<article-title>How generation intervals shape the relationship between growth rates and reproductive numbers</article-title>. <source/>Proc Biol Sci. <year>2007</year>;<volume>274</volume>(<issue>1609</issue>):<fpage>599</fpage>–<lpage>604</lpage>.<pub-id pub-id-type="pmid">17476782</pub-id></mixed-citation>
</ref>
<ref id="kwy264C86">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wallinga</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Teunis</surname><given-names>P</given-names></name></person-group>
<article-title>Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures</article-title>. <source/>Am J Epidemiol. <year>2004</year>;<volume>160</volume>(<issue>6</issue>):<fpage>509</fpage>–<lpage>516</lpage>.<pub-id pub-id-type="pmid">15353409</pub-id></mixed-citation>
</ref>
<ref id="kwy264C87">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Eddy</surname><given-names>RG</given-names></name></person-group>
<article-title>Vets asked valuable questions about foot-and-mouth measures</article-title>. <source/>Nature. <year>2001</year>;<volume>412</volume>(<issue>6846</issue>):<fpage>477</fpage>.</mixed-citation>
</ref>
<ref id="kwy264C88">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Butler</surname><given-names>D</given-names></name></person-group>
<article-title>Models overestimate Ebola cases</article-title>. <source/>Nature. <year>2014</year>;<volume>515</volume>(<issue>7525</issue>):<fpage>18</fpage>.<pub-id pub-id-type="pmid">25373654</pub-id></mixed-citation>
</ref>
<ref id="kwy264C89">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lofgren</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Halloran</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Rivers</surname><given-names>CM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Opinion: mathematical models: a key tool for outbreak response</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2014</year>;<volume>111</volume>(<issue>51</issue>):<fpage>18095</fpage>–<lpage>18096</lpage>.<pub-id pub-id-type="pmid">25502594</pub-id></mixed-citation>
</ref>
<ref id="kwy264C90">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rivers</surname><given-names>C</given-names></name></person-group>
<article-title>Ebola: models do more than forecast</article-title>. <source/>Nature. <year>2014</year>;<volume>515</volume>(<issue>7528</issue>):<fpage>492</fpage>.</mixed-citation>
</ref>
<ref id="kwy264C91">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Camacho</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Flasche</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Measuring the impact of Ebola control measures in Sierra Leone</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2015</year>;<volume>112</volume>(<issue>46</issue>):<fpage>14366</fpage>–<lpage>14371</lpage>.<pub-id pub-id-type="pmid">26460023</pub-id></mixed-citation>
</ref>
<ref id="kwy264C92">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ou</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Ciesielski</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Molecular epidemiology of HIV transmission in a dental practice</article-title>. <source/>Science. <year>1992</year>;<volume>256</volume>(<issue>5060</issue>):<fpage>1165</fpage>–<lpage>1171</lpage>.<pub-id pub-id-type="pmid">1589796</pub-id></mixed-citation>
</ref>
<ref id="kwy264C93">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Sorenson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>JB</given-names></name>, <etal>et al</etal></person-group>
<article-title>The origin of the Haitian cholera outbreak strain</article-title>. <source/>N Engl J Med. <year>2011</year>;<volume>364</volume>:<fpage>33</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="pmid">21142692</pub-id></mixed-citation>
</ref>
<ref id="kwy264C94">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gire</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Goba</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>KG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak</article-title>. <source/>Science. <year>2014</year>;<volume>345</volume>(<issue>6202</issue>):<fpage>1369</fpage>–<lpage>1372</lpage>.<pub-id pub-id-type="pmid">25214632</pub-id></mixed-citation>
</ref>
<ref id="kwy264C95">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dudas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Bedford</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Virus genomes reveal factors that spread and sustained the Ebola epidemic</article-title>. <source/>Nature. <year>2017</year>;<volume>544</volume>(<issue>7650</issue>):<fpage>309</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">28405027</pub-id></mixed-citation>
</ref>
<ref id="kwy264C96">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Metsky</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Matranga</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Wohl</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Zika virus evolution and spread in the Americas</article-title>. <source/>Nature. <year>2017</year>;<volume>546</volume>(<issue>7658</issue>):<fpage>411</fpage>–<lpage>415</lpage>.<pub-id pub-id-type="pmid">28538734</pub-id></mixed-citation>
</ref>
<ref id="kwy264C97">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Scarpino</surname><given-names>SV</given-names></name>, <name name-style="western"><surname>Iamarino</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Epidemiological and viral genomic sequence analysis of the 2014 Ebola outbreak reveals clustered transmission</article-title>. <source/>Clin Infect Dis. <year>2015</year>;<volume>60</volume>(<issue>7</issue>):<fpage>1079</fpage>–<lpage>1082</lpage>.<pub-id pub-id-type="pmid">25516185</pub-id></mixed-citation>
</ref>
<ref id="kwy264C98">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dudas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Carvalho</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Rambaut</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>MERS-CoV spillover at the camel-human interface</article-title>. <source/>ELife. <year>2018</year>;<volume>7</volume>:<fpage>e31257</fpage>.<pub-id pub-id-type="pmid">29336306</pub-id></mixed-citation>
</ref>
<ref id="kwy264C99">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Grassly</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name></person-group>
<article-title>Genomic analysis of emerging pathogens: methods, application and future trends</article-title>. <source/>Genome Biol. <year>2014</year>;<volume>15</volume>(<issue>11</issue>):<fpage>541</fpage>.<pub-id pub-id-type="pmid">25418281</pub-id></mixed-citation>
</ref>
<ref id="kwy264C100">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grubaugh</surname><given-names>ND</given-names></name>, <name name-style="western"><surname>Ladner</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Kraemer</surname><given-names>MUG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Genomic epidemiology reveals multiple introductions of Zika virus into the United States</article-title>. <source/>Nature. <year>2017</year>;<volume>546</volume>(<issue>7658</issue>):<fpage>401</fpage>–<lpage>405</lpage>.<pub-id pub-id-type="pmid">28538723</pub-id></mixed-citation>
</ref>
<ref id="kwy264C101">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Faria</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Kraemer</surname><given-names>MUG</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>SC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Genomic and epidemiological monitoring of yellow fever virus transmission potential</article-title>. <source/>Science. <year>2018</year>;<volume>361</volume>(<issue>6405</issue>):<fpage>894</fpage>–<lpage>899</lpage>.<pub-id pub-id-type="pmid">30139911</pub-id></mixed-citation>
</ref>
<ref id="kwy264C102">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wohl</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Metsky</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Schaffner</surname><given-names>SF</given-names></name>, <etal>et al</etal></person-group>
<article-title>Co-circulating mumps lineages at multiple geographic scales</article-title> [published online ahead of print June 12, 2018]. <source/>bioRxiv. <year>2018</year>. (doi: <pub-id pub-id-type="doi">10.1101/343897</pub-id>). Accessed 28 November, 2018.</mixed-citation>
</ref>
<ref id="kwy264C103">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Stoesser</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Giess</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Batty</surname><given-names>EM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Genome sequencing of an extended series of NDM-producing <italic>Klebsiella pneumoniae</italic> isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic setting</article-title>. <source/>Antimicrob Agents Chemother. <year>2014</year>;<volume>58</volume>(<issue>12</issue>):<fpage>7347</fpage>–<lpage>7357</lpage>.<pub-id pub-id-type="pmid">25267672</pub-id></mixed-citation>
</ref>
<ref id="kwy264C104">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Klinkenberg</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Backer</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Didelot</surname><given-names>X</given-names></name>, <etal>et al</etal></person-group>
<article-title>Simultaneous inference of phylogenetic and transmission trees in infectious disease outbreaks</article-title>. <source/>PLoS Comput Biol. <year>2017</year>;<volume>13</volume>(<issue>5</issue>):<fpage>e1005495</fpage>.<pub-id pub-id-type="pmid">28545083</pub-id></mixed-citation>
</ref>
<ref id="kwy264C105">
<label>105</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Røttingen</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Gouglas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Feinberg</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>New vaccines against epidemic infectious diseases</article-title>. <source/>N Engl J Med. <year>2017</year>;<volume>376</volume>(<issue>7</issue>):<fpage>610</fpage>–<lpage>613</lpage>.<pub-id pub-id-type="pmid">28099066</pub-id></mixed-citation>
</ref>
<ref id="kwy264C106">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brende</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Farrar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Gashumba</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>CEPI—a new global R&amp;D organisation for epidemic preparedness and response</article-title>. <source/>Lancet. <year>2017</year>;<volume>389</volume>(<issue>10066</issue>):<fpage>233</fpage>–<lpage>235</lpage>.<pub-id pub-id-type="pmid">28109539</pub-id></mixed-citation>
</ref>
<ref id="kwy264C107">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Bolay</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kieh</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia</article-title>. <source/>N Engl J Med. <year>2017</year>;<volume>377</volume>(<issue>15</issue>):<fpage>1438</fpage>–<lpage>1447</lpage>.<pub-id pub-id-type="pmid">29020589</pub-id></mixed-citation>
</ref>
<ref id="kwy264C108">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Widdowson</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Schrag</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>RJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Implementing an Ebola vaccine study—Sierra Leone</article-title>. <source/>MMWR Suppl. <year>2016</year>;<volume>65</volume>(<issue>3</issue>):<fpage>98</fpage>–<lpage>106</lpage>.<pub-id pub-id-type="pmid">27387395</pub-id></mixed-citation>
</ref>
<ref id="kwy264C109">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Henao-Restrepo</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Camacho</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Longini</surname><given-names>IM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)</article-title>. <source/>Lancet. <year>2017</year>;<volume>389</volume>(<issue>10068</issue>):<fpage>505</fpage>–<lpage>518</lpage>.<pub-id pub-id-type="pmid">28017403</pub-id></mixed-citation>
</ref>
<ref id="kwy264C110">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Camacho</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Dean</surname><given-names>NE</given-names></name>, <etal>et al</etal></person-group>
<article-title>The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola</article-title>. <source/>BMJ. <year>2015</year>;<volume>351</volume>:<fpage>h3740</fpage>.<pub-id pub-id-type="pmid">26215666</pub-id></mixed-citation>
</ref>
<ref id="kwy264C111">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bellan</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Pulliam</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Pearson</surname><given-names>CA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis</article-title>. <source/>Lancet Infect Dis. <year>2015</year>;<volume>15</volume>(<issue>6</issue>):<fpage>703</fpage>–<lpage>710</lpage>.<pub-id pub-id-type="pmid">25886798</pub-id></mixed-citation>
</ref>
<ref id="kwy264C112">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kahn</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rid</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>PG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Choices in vaccine trial design for epidemics of emerging infections</article-title>. <source/>PLoS Med. <year>2018</year>;<volume>15</volume>(<issue>8</issue>):<fpage>e1002632</fpage>.<pub-id pub-id-type="pmid">30086139</pub-id></mixed-citation>
</ref>
<ref id="kwy264C113">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Camacho</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Eggo</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Goeyvaerts</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone</article-title>. <source/>Vaccine. <year>2017</year>;<volume>35</volume>(<issue>4</issue>):<fpage>544</fpage>–<lpage>551</lpage>.<pub-id pub-id-type="pmid">28024952</pub-id></mixed-citation>
</ref>
<ref id="kwy264C114">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Halloran</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Auranen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Baird</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Simulations for designing and interpreting intervention trials in infectious diseases</article-title>. <source/>BMC Med. <year>2017</year>;<volume>15</volume>:<fpage>223</fpage>.<pub-id pub-id-type="pmid">29287587</pub-id></mixed-citation>
</ref>
<ref id="kwy264C115">
<label>115</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name name-style="western"><surname>Berry</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Carlin</surname><given-names>BP</given-names></name>, <name name-style="western"><surname>Jack Lee</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<source/>Bayesian Adaptive Methods for Clinical Trials. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press</publisher-name>; <year>2010</year>.</mixed-citation>
</ref>
<ref id="kwy264C116">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>LA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Influenza vaccine effectiveness in the United States during the 2015–2016 season</article-title>. <source/>N Engl J Med. <year>2017</year>;<volume>377</volume>(<issue>6</issue>):<fpage>534</fpage>–<lpage>543</lpage>.<pub-id pub-id-type="pmid">28792867</pub-id></mixed-citation>
</ref>
<ref id="kwy264C117">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Petousis-Harris</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Paynter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study</article-title>. <source/>Lancet. <year>2017</year>;<volume>390</volume>(<issue>10102</issue>):<fpage>1603</fpage>–<lpage>1610</lpage>.<pub-id pub-id-type="pmid">28705462</pub-id></mixed-citation>
</ref>
<ref id="kwy264C118">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Foppa</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Haber</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ferdinands</surname><given-names>JM</given-names></name>, <etal>et al</etal></person-group>
<article-title>The case test-negative design for studies of the effectiveness of influenza vaccine</article-title>. <source/>Vaccine. <year>2013</year>;<volume>31</volume>(<issue>30</issue>):<fpage>3104</fpage>–<lpage>3109</lpage>.<pub-id pub-id-type="pmid">23624093</pub-id></mixed-citation>
</ref>
<ref id="kwy264C119">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Tchetgen Tchetgen</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Cowling</surname><given-names>BJ</given-names></name></person-group>
<article-title>Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness</article-title>. <source/>Am J Epidemiol. <year>2016</year>;<volume>184</volume>(<issue>5</issue>):<fpage>345</fpage>–<lpage>353</lpage>.<pub-id pub-id-type="pmid">27587721</pub-id></mixed-citation>
</ref>
<ref id="kwy264C120">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lewnard</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Tedijanto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cowling</surname><given-names>BJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Measurement of vaccine direct effects under the test-negative design</article-title>. <source/>Am J Epidemiol. <year>2018</year>;<volume>187</volume>(<issue>12</issue>):<fpage>2686</fpage>–<lpage>2697</lpage>.<pub-id pub-id-type="pmid">30099505</pub-id></mixed-citation>
</ref>
<ref id="kwy264C121">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gross</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Hermogenes</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Sacks</surname><given-names>HS</given-names></name>, <etal>et al</etal></person-group>
<article-title>The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature</article-title>. <source/>Ann Intern Med. <year>1995</year>;<volume>123</volume>(<issue>7</issue>):<fpage>518</fpage>–<lpage>527</lpage>.<pub-id pub-id-type="pmid">7661497</pub-id></mixed-citation>
</ref>
<ref id="kwy264C122">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Simonsen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Reichert</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Viboud</surname><given-names>C</given-names></name></person-group>
<article-title>Impact of influenza vaccination on seasonal mortality in the US elderly population</article-title>. <source/>Arch Intern Med. <year>2005</year>;<volume>165</volume>(<issue>3</issue>):<fpage>265</fpage>–<lpage>272</lpage>.<pub-id pub-id-type="pmid">15710788</pub-id></mixed-citation>
</ref>
<ref id="kwy264C123">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Rizzo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Viboud</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Montomoli</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage</article-title>. <source/>Vaccine. <year>2006</year>;<volume>24</volume>(<issue>42–43</issue>):<fpage>6468</fpage>–<lpage>6475</lpage>.<pub-id pub-id-type="pmid">16876293</pub-id></mixed-citation>
</ref>
<ref id="kwy264C124">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Link-Gelles</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schaffner</surname><given-names>W</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance</article-title>. <source/>Lancet Infect Dis. <year>2015</year>;<volume>15</volume>(<issue>3</issue>):<fpage>301</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">25656600</pub-id></mixed-citation>
</ref>
<ref id="kwy264C125">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kürüm</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Schuck-Paim</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Bayesian model averaging with change points to assess the impact of vaccination and public health interventions</article-title>. <source/>Epidemiology. <year>2017</year>;<volume>28</volume>(<issue>6</issue>):<fpage>889</fpage>–<lpage>897</lpage>.<pub-id pub-id-type="pmid">28767518</pub-id></mixed-citation>
</ref>
<ref id="kwy264C126">
<label>126</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name></person-group>
<article-title>The estimation of age-related rates of infection from case notifications and serological data</article-title>. <source/>J Hyg (Lond). <year>1985</year>;<volume>95</volume>(<issue>2</issue>):<fpage>419</fpage>–<lpage>436</lpage>.<pub-id pub-id-type="pmid">4067297</pub-id></mixed-citation>
</ref>
<ref id="kwy264C127">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Earn</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Rohani</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bolker</surname><given-names>BM</given-names></name>, <etal>et al</etal></person-group>
<article-title>A simple model for complex dynamical transitions in epidemics</article-title>. <source/>Science. <year>2000</year>;<volume>287</volume>(<issue>5453</issue>):<fpage>667</fpage>–<lpage>670</lpage>.<pub-id pub-id-type="pmid">10650003</pub-id></mixed-citation>
</ref>
<ref id="kwy264C128">
<label>128</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chaves</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Gargiullo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>JX</given-names></name>, <etal>et al</etal></person-group>
<article-title>Loss of vaccine-induced immunity to varicella over time</article-title>. <source/>N Engl J Med. <year>2007</year>;<volume>356</volume>(<issue>11</issue>):<fpage>1121</fpage>–<lpage>1129</lpage>.<pub-id pub-id-type="pmid">17360990</pub-id></mixed-citation>
</ref>
<ref id="kwy264C129">
<label>129</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gilbert</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Self</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation</article-title>. <source/>J Clin Epidemiol. <year>2001</year>;<volume>54</volume>(<issue>1</issue>):<fpage>68</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">11165470</pub-id></mixed-citation>
</ref>
<ref id="kwy264C130">
<label>130</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Power</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Parkhill</surname><given-names>J</given-names></name>, <name name-style="western"><surname>de Oliveira</surname><given-names>T</given-names></name></person-group>
<article-title>Microbial genome-wide association studies: lessons from human GWAS</article-title>. <source/>Nat Rev Genet. <year>2017</year>;<volume>18</volume>:<fpage>41</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">27840430</pub-id></mixed-citation>
</ref>
<ref id="kwy264C131">
<label>131</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sealey</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Fry</surname><given-names>NK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving</article-title>. <source/>J Infect Dis. <year>2015</year>;<volume>212</volume>(<issue>2</issue>):<fpage>294</fpage>–<lpage>301</lpage>.<pub-id pub-id-type="pmid">25489002</pub-id></mixed-citation>
</ref>
<ref id="kwy264C132">
<label>132</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Gargiullo</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Massoudi</surname><given-names>MS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Intussusception among infants given an oral rotavirus vaccine</article-title>. <source/>N Engl J Med. <year>2001</year>;<volume>344</volume>(<issue>8</issue>):<fpage>564</fpage>–<lpage>572</lpage>.<pub-id pub-id-type="pmid">11207352</pub-id></mixed-citation>
</ref>
<ref id="kwy264C133">
<label>133</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Farrington</surname><given-names>CP</given-names></name>, <etal>et al</etal></person-group>
<article-title>Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association</article-title>. <source/>Lancet. <year>1999</year>;<volume>353</volume>(<issue>9169</issue>):<fpage>2026</fpage>–<lpage>2029</lpage>.<pub-id pub-id-type="pmid">10376617</pub-id></mixed-citation>
</ref>
<ref id="kwy264C134">
<label>134</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dourado</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Cunha</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Teixeira</surname><given-names>MG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs</article-title>. <source/>Am J Epidemiol. <year>2000</year>;<volume>151</volume>(<issue>5</issue>):<fpage>524</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">10707922</pub-id></mixed-citation>
</ref>
<ref id="kwy264C135">
<label>135</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shields</surname><given-names>WD</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Buch</surname><given-names>D</given-names></name>, <etal>et al</etal></person-group>
<article-title>Relationship of pertussis immunization to the onset of neurologic disorders: a retrospective epidemiologic study</article-title>. <source/>J Pediatr. <year>1988</year>;<volume>113</volume>(<issue>5</issue>):<fpage>801</fpage>–<lpage>805</lpage>.<pub-id pub-id-type="pmid">3263484</pub-id></mixed-citation>
</ref>
<ref id="kwy264C136">
<label>136</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Choe</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>DH</given-names></name></person-group>
<article-title>No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study</article-title>. <source/>Vaccine. <year>2012</year>;<volume>30</volume>(<issue>52</issue>):<fpage>7439</fpage>–<lpage>7442</lpage>.<pub-id pub-id-type="pmid">23088885</pub-id></mixed-citation>
</ref>
<ref id="kwy264C137">
<label>137</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Warby</surname><given-names>SC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China</article-title>. <source/>Ann Neurol. <year>2011</year>;<volume>70</volume>(<issue>3</issue>):<fpage>410</fpage>–<lpage>417</lpage>.<pub-id pub-id-type="pmid">21866560</pub-id></mixed-citation>
</ref>
<ref id="kwy264C138">
<label>138</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hambidge</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Glanz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>France</surname><given-names>EK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old</article-title>. <source/>JAMA. <year>2006</year>;<volume>296</volume>(<issue>16</issue>):<fpage>1990</fpage>–<lpage>1997</lpage>.<pub-id pub-id-type="pmid">17062862</pub-id></mixed-citation>
</ref>
<ref id="kwy264C139">
<label>139</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>SG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design</article-title>. <source/>Am J Epidemiol. <year>2003</year>;<volume>157</volume>(<issue>2</issue>):<fpage>158</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">12522023</pub-id></mixed-citation>
</ref>
<ref id="kwy264C140">
<label>140</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Farrington</surname><given-names>CP</given-names></name></person-group>
<article-title>Relative incidence estimation from case series for vaccine safety evaluation</article-title>. <source/>Biometrics. <year>1995</year>;<volume>51</volume>(<issue>1</issue>):<fpage>228</fpage>–<lpage>235</lpage>.<pub-id pub-id-type="pmid">7766778</pub-id></mixed-citation>
</ref>
<ref id="kwy264C141">
<label>141</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tacconelli</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Carrara</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Savoldi</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis</article-title>. <source/>Lancet Infect Dis. <year>2018</year>;<volume>18</volume>(<issue>3</issue>):<fpage>318</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">29276051</pub-id></mixed-citation>
</ref>
<ref id="kwy264C142">
<label>142</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Perrot</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>N</given-names></name></person-group>
<article-title>Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria</article-title>. <source/>Genetics. <year>2000</year>;<volume>154</volume>(<issue>3</issue>):<fpage>985</fpage>–<lpage>997</lpage>.<pub-id pub-id-type="pmid">10757748</pub-id></mixed-citation>
</ref>
<ref id="kwy264C143">
<label>143</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Martínez</surname><given-names>JL</given-names></name></person-group>
<article-title>Antibiotics and antibiotic resistance genes in natural environments</article-title>. <source/>Science. <year>2008</year>;<volume>321</volume>(<issue>5887</issue>):<fpage>365</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">18635792</pub-id></mixed-citation>
</ref>
<ref id="kwy264C144">
<label>144</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Siu</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Conley</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Boerner</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Next-generation sequencing to guide clinical trials</article-title>. <source/>Clin Cancer Res. <year>2015</year>;<volume>21</volume>(<issue>20</issue>):<fpage>4536</fpage>–<lpage>4544</lpage>.<pub-id pub-id-type="pmid">26473189</pub-id></mixed-citation>
</ref>
<ref id="kwy264C145">
<label>145</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tedijanto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Olesen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grad</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora</article-title>. <source/>bioRxiv. <year>2018</year>. (doi: <pub-id pub-id-type="doi">10.1101/288704</pub-id>). Accessed 28 November, 2018.</mixed-citation>
</ref>
<ref id="kwy264C146">
<label>146</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name></person-group>
<article-title>Measuring and interpreting associations between antibiotic use and penicillin resistance in <italic>Streptococcus pneumoniae</italic></article-title>. <source/>Clin Infect Dis. <year>2001</year>;<volume>32</volume>(<issue>7</issue>):<fpage>1044</fpage>–<lpage>1054</lpage>.<pub-id pub-id-type="pmid">11264033</pub-id></mixed-citation>
</ref>
<ref id="kwy264C147">
<label>147</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Schrag</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Peña</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Fernández</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial</article-title>. <source/>JAMA. <year>2001</year>;<volume>286</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">11434826</pub-id></mixed-citation>
</ref>
<ref id="kwy264C148">
<label>148</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Feikin</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Dowell</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Nwanyanwu</surname><given-names>OC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increased carriage of trimethoprim/sulfamethoxazole-resistant <italic>Streptococcus pneumoniae</italic> in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine</article-title>. <source/>J Infect Dis. <year>2000</year>;<volume>181</volume>(<issue>4</issue>):<fpage>1501</fpage>–<lpage>1505</lpage>.<pub-id pub-id-type="pmid">10762585</pub-id></mixed-citation>
</ref>
<ref id="kwy264C149">
<label>149</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Colijn</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>No coexistence for free: neutral null models for multistrain pathogens</article-title>. <source/>Epidemics. <year>2009</year>;<volume>1</volume>(<issue>1</issue>):<fpage>2</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">21352747</pub-id></mixed-citation>
</ref>
<ref id="kwy264C150">
<label>150</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lewnard</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Tähtinen</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Laine</surname><given-names>MK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Impact of antimicrobial treatment for acute otitis media on carriage dynamics of penicillin-susceptible and penicillin-nonsusceptible <italic>Streptococcus pneumoniae</italic></article-title>. <source/>J Infect Dis. <year>2018</year>;<volume>218</volume>(<issue>9</issue>):<fpage>1356</fpage>–<lpage>1366</lpage>.<pub-id pub-id-type="pmid">29873739</pub-id></mixed-citation>
</ref>
<ref id="kwy264C151">
<label>151</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tähtinen</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Laine</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Huovinen</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>A placebo-controlled trial of antimicrobial treatment for acute otitis media</article-title>. <source/>N Engl J Med. <year>2011</year>;<volume>364</volume>(<issue>2</issue>):<fpage>116</fpage>–<lpage>126</lpage>.<pub-id pub-id-type="pmid">21226577</pub-id></mixed-citation>
</ref>
<ref id="kwy264C152">
<label>152</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lessem</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>C</given-names></name>, <etal>et al</etal></person-group>
<article-title>Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives</article-title>. <source/>Int J Infect Dis. <year>2015</year>;<volume>32</volume>:<fpage>56</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">25809757</pub-id></mixed-citation>
</ref>
<ref id="kwy264C153">
<label>153</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kunkel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cobelens</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>T</given-names></name></person-group>
<article-title>Tradeoffs in introduction policies for the anti-tuberculosis drug bedaquiline: a model-based analysis</article-title>. <source/>PLoS Med. <year>2016</year>;<volume>13</volume>(<issue>10</issue>):<fpage>e1002142</fpage>.<pub-id pub-id-type="pmid">27727274</pub-id></mixed-citation>
</ref>
<ref id="kwy264C154">
<label>154</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kunkel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Furin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>T</given-names></name></person-group>
<article-title>Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?</article-title><source/>Lancet Infect Dis. <year>2017</year>;<volume>17</volume>(<issue>12</issue>):<fpage>e429</fpage>–<lpage>e433</lpage>.<pub-id pub-id-type="pmid">28533094</pub-id></mixed-citation>
</ref>
<ref id="kwy264C155">
<label>155</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bergstrom</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Lo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name></person-group>
<article-title>Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2004</year>;<volume>101</volume>(<issue>36</issue>):<fpage>13285</fpage>–<lpage>13290</lpage>.<pub-id pub-id-type="pmid">15308772</pub-id></mixed-citation>
</ref>
<ref id="kwy264C156">
<label>156</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>van Duijn</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Verbrugghe</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Jorens</surname><given-names>PG</given-names></name>, <etal>et al</etal></person-group>
<article-title>The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial</article-title>. <source/>Lancet Infect Dis. <year>2018</year>;<volume>18</volume>(<issue>4</issue>):<fpage>401</fpage>–<lpage>409</lpage>.<pub-id pub-id-type="pmid">29396000</pub-id></mixed-citation>
</ref>
<ref id="kwy264C157">
<label>157</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kuiken</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Leighton</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Fouchier</surname><given-names>RA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Public health. Pathogen surveillance in animals</article-title>. <source/>Science. <year>2005</year>;<volume>309</volume>(<issue>5741</issue>):<fpage>1680</fpage>–<lpage>1681</lpage>.<pub-id pub-id-type="pmid">16150997</pub-id></mixed-citation>
</ref>
<ref id="kwy264C158">
<label>158</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>AS</given-names></name></person-group>
<article-title>Causation and disease: a chronological journey. The Thomas Parran Lecture. 1978</article-title>. <source/>Am J Epidemiol. <year>1978</year>;<volume>108</volume>(<issue>4</issue>):<fpage>249</fpage>–<lpage>258</lpage>.<pub-id pub-id-type="pmid">727194</pub-id></mixed-citation>
</ref>
<ref id="kwy264C159">
<label>159</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fredericks</surname><given-names>DN</given-names></name>, <name name-style="western"><surname>Relman</surname><given-names>DA</given-names></name></person-group>
<article-title>Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates</article-title>. <source/>Clin Microbiol Rev. <year>1996</year>;<volume>9</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">8665474</pub-id></mixed-citation>
</ref>
<ref id="kwy264C160">
<label>160</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Muñoz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Castellsagué</surname><given-names>X</given-names></name>, <name name-style="western"><surname>de González</surname><given-names>AB</given-names></name>, <etal>et al</etal></person-group>
<article-title>HPV in the etiology of human cancer</article-title>. <source/>Vaccine. <year>2006</year>;<volume>24</volume>(<issue>suppl 3</issue>):<fpage>S1</fpage>–<lpage>S10</lpage>.<pub-id pub-id-type="pmid">16406226</pub-id></mixed-citation>
</ref>
<ref id="kwy264C161">
<label>161</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>DY</given-names></name>, <name name-style="western"><surname>Lew</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>PD</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of treatment of <italic>Helicobacter pylori</italic> infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study</article-title>. <source/>Ann Intern Med. <year>1992</year>;<volume>116</volume>(<issue>9</issue>):<fpage>705</fpage>–<lpage>708</lpage>.<pub-id pub-id-type="pmid">1558340</pub-id></mixed-citation>
</ref>
<ref id="kwy264C162">
<label>162</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Blanken</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Rovers</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Molenaar</surname><given-names>JM</given-names></name>, <etal>et al</etal></person-group>
<article-title>Respiratory syncytial virus and recurrent wheeze in healthy preterm infants</article-title>. <source/>N Engl J Med. <year>2013</year>;<volume>368</volume>(<issue>19</issue>):<fpage>1791</fpage>–<lpage>1799</lpage>.<pub-id pub-id-type="pmid">23656644</pub-id></mixed-citation>
</ref>
<ref id="kwy264C163">
<label>163</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mina</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Metcalf</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>de Swart</surname><given-names>RL</given-names></name>, <etal>et al</etal></person-group>
<article-title>Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality</article-title>. <source/>Science. <year>2015</year>;<volume>348</volume>(<issue>6235</issue>):<fpage>694</fpage>–<lpage>699</lpage>.<pub-id pub-id-type="pmid">25954009</pub-id></mixed-citation>
</ref>
<ref id="kwy264C164">
<label>164</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>MAL-ED Network Investigators</collab></person-group>
<article-title>The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments</article-title>. <source/>Clin Infect Dis. <year>2014</year>;<volume>59</volume>(<issue>suppl 4</issue>):<fpage>S193</fpage>–<lpage>S206</lpage>.<pub-id pub-id-type="pmid">25305287</pub-id></mixed-citation>
</ref>
<ref id="kwy264C165">
<label>165</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dagan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pelton</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bakaletz</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prevention of early episodes of otitis media by pneumococcal vaccines might reduce progression to complex disease</article-title>. <source/>Lancet Infect Dis. <year>2016</year>;<volume>16</volume>(<issue>4</issue>):<fpage>480</fpage>–<lpage>492</lpage>.<pub-id pub-id-type="pmid">27036355</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>